amantadine has been researched along with Respiratory Distress Syndrome in 3 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
Excerpt | Relevance | Reference |
---|---|---|
"The 2009 pandemic influenza A (H1N1) was a considerable public health concern worldwide." | 1.39 | Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection. ( Jang, HC; Jung, SI; Kang, SJ; Kee, SJ; Kwon, YS; Park, KH; Shin, JH, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Brenner, SR | 1 |
Gomes, CP | 1 |
Fernandes, DE | 1 |
Casimiro, F | 1 |
da Mata, GF | 1 |
Passos, MT | 1 |
Varela, P | 1 |
Mastroianni-Kirsztajn, G | 1 |
Pesquero, JB | 1 |
Kang, SJ | 1 |
Park, KH | 1 |
Kee, SJ | 1 |
Shin, JH | 1 |
Jung, SI | 1 |
Kwon, YS | 1 |
Jang, HC | 1 |
1 review available for amantadine and Respiratory Distress Syndrome
Article | Year |
---|---|
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.
Topics: Acute Kidney Injury; Amantadine; Angiotensin-Converting Enzyme 2; Cathepsin L; Chloroquine; COVID-19 | 2020 |
2 other studies available for amantadine and Respiratory Distress Syndrome
Article | Year |
---|---|
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
Topics: Adamantane; Amantadine; COVID-19; Humans; Lysosomes; Memantine; Respiratory Distress Syndrome; Respi | 2020 |
Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Humans; In | 2013 |